Analysis Of Income And Expense [Abstract]

Affluent Medical - Filing #2810675

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
- EUR
- EUR
Material income and expense [abstract]
Finance income (cost)
Other finance income (cost)
1,000 EUR
29,000 EUR
Gains (losses) on change in fair value of derivatives [abstract]
Gains (losses) on change in fair value of derivatives
3,000 EUR
60,000 EUR
Expenses by nature [abstract]
Raw materials and consumables used
2 132 EUR
2 443 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense
6 141 EUR
5 213 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
2 413 EUR
2 450 EUR
Impairment loss (reversal of impairment loss) recognised in profit or loss
- EUR
119,000 EUR
Tax expense other than income tax expense
97,000 EUR
85,000 EUR
Other expenses, by nature
6 017 EUR
5 566 EUR
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations
- EUR
- EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
- EUR
- EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
15 653 EUR
- EUR
15 622 EUR
31,000 EUR
- EUR
- EUR
15 622 EUR
- EUR
- EUR
15 215 EUR
15 215 EUR
- EUR
12,000 EUR
15 227 EUR
0 EUR
- EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
15 622 EUR
15 215 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.